Article Cited by others

REVIEW ARTICLE

Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients

Chadda Rakesh K, Ramshankar Prashanth, Deb Koushik S, Sood Mamta, Chadda Rakesh K, Ramshankar Prashanth, Deb Koushik S, Sood Mamta

Year : 2013| Volume: 4| Issue : 3 | Page no: 176-186

   This article has been cited by
 
1 Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats
Cuilian Guo, Jinxin Liu, Huqun Li
Biomedicine & Pharmacotherapy. 2021; 133: 110912
[Pubmed]  [Google Scholar] [DOI]
2 Metabolic syndrome in antipsychotic-naïve patients with first-episode psychosis: a systematic review and meta-analysis
Nathalia Garrido-Torres, Idalino Rocha-Gonzalez, Luis Alameda, Aurora Rodriguez-Gangoso, Ana Vilches, Manuel Canal-Rivero, Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla
Psychological Medicine. 2021; 51(14): 2307
[Pubmed]  [Google Scholar] [DOI]
3 The Role of Medical Comorbidity in the Rapid Psychiatric Readmission of Patients With Schizophrenia-spectrum Disorders
LAUREN E. REEVES, LAUREN WEINSTOCK, GARY EPSTEIN-LUBOW, JANE METRIK, BRANDON A. GAUDIANO
Journal of Psychiatric Practice. 2021; 27(1): 14
[Pubmed]  [Google Scholar] [DOI]
4 Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players
Juan D. Molina, Sonia Avila, Gabriel Rubio, Francisco López-Muñoz
Current Pharmaceutical Design. 2021; 27(39): 4049
[Pubmed]  [Google Scholar] [DOI]
5 The Association Between Metabolic Disturbance and Cognitive Impairments in Early-Stage Schizophrenia
Xing-Jie Peng, Gang-Rui Hei, Ran-Ran Li, Ye Yang, Chen-Chen Liu, Jing-Mei Xiao, Yu-Jun Long, Ping Shao, Jing Huang, Jing-Ping Zhao, Ren-Rong Wu
Frontiers in Human Neuroscience. 2021; 14
[Pubmed]  [Google Scholar] [DOI]
6 Low-carbohydrate diet improves the cardiopsychiatry profile of patients with schizophrenia: A pilot study
NoorJ Altooq, SafaAbduljalil Aburowais, AhmedN Alajaimi, IsaY Albanna, OmarA Alhaj, HaithamA Jahrami
Heart and Mind. 2021; 5(3): 80
[Pubmed]  [Google Scholar] [DOI]
7 Management of Drug-induced Weight Gain in Persons Receiving Psychotropic Drugs
Vikas Menon, Samir K Praharaj
Indian Journal of Private Psychiatry. 2021; 15(1): 10
[Pubmed]  [Google Scholar] [DOI]
8 Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome
Elena G. Kornetova, Alexander N. Kornetov, Irina A. Mednova, Olga A. Lobacheva, Valeria I. Gerasimova, Viktoria V. Dubrovskaya, Ivan V. Tolmachev, Arkadiy V. Semke, Anton J. M. Loonen, Nikolay A. Bokhan, Svetlana A. Ivanova
Diagnostics. 2020; 10(9): 683
[Pubmed]  [Google Scholar] [DOI]
9 A Study of Metabolic Syndrome in Patients on Risperidone
Ajay Thangraj, Nimesh G. Desai, Vijender Singh
Current Psychopharmacology. 2020; 9(3): 218
[Pubmed]  [Google Scholar] [DOI]
10 A propensity score matching analysis for cardio metabolic risk of antipsychotics in patients with schizophrenia using Japanese claims data
Ichiro Kusumi, Sachie Inoue, Kenji Baba, Tadashi Nosaka, Toshihisa Anzai
BMC Psychiatry. 2020; 20(1)
[Pubmed]  [Google Scholar] [DOI]
11 Evaluation of arterial stiffness in patients with schizophrenia
Sema Baykara, Pinar Gündogan Bozdag, Murat Baykara, Mustafa Nuray Namli
Journal of Clinical Neuroscience. 2020; 79: 149
[Pubmed]  [Google Scholar] [DOI]
12 Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia
Marina Sagud,Suzana Vlatkovic,Dubravka Svob Strac,Mario Sviben,Maja Zivkovic,Maja Vilibic,Bjanka Vuksan-Cusa,Alma Mihaljevic-Peles,Nela Pivac
Comprehensive Psychiatry. 2018; 82: 115
[Pubmed]  [Google Scholar] [DOI]
13 QT dispersion and P wave dispersion in schizophrenia
Sema Baykara,Mücahit Yilmaz,Murat Baykara
Psychiatry and Clinical Psychopharmacology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
14 Dysglycaemia, Inflammation and Psychosis: Findings From the UK ALSPAC Birth Cohort
Benjamin Ian Perry,Rachel Upthegrove,Andrew Thompson,Steven Marwaha,Stanley Zammit,Swaran Preet Singh,Golam Khandaker
Schizophrenia Bulletin. 2018;
[Pubmed]  [Google Scholar] [DOI]
15 Complex Polypharmacy in Patients With Schizophrenia-Spectrum Disorders Before a Psychiatric Hospitalization
Brandon A. Gaudiano,Carolina Guzman Holst,Alexandra Morena,Lauren E. Reeves,Valerie J. Sydnor,Gary Epstein-Lubow,Lauren M. Weinstock
Journal of Clinical Psychopharmacology. 2018; 38(3): 180
[Pubmed]  [Google Scholar] [DOI]
16 Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits
Hon-Cheong So,Kwan-Long Chau,Fu-Kiu Ao,Cheuk-Hei Mo,Pak-Chung Sham
Psychological Medicine. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
17 The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
Ranran Li,Jianjun Ou,Li Li,Ye Yang,Jingping Zhao,Renrong Wu
Frontiers in Pharmacology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
18 The Obesity–Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients
Adonis Sfera,Carolina Osorio,Luzmin Acosta Inderias,Victoria Parker,Amy I. Price,Michael Cummings
Frontiers in Psychiatry. 2017; 8
[Pubmed]  [Google Scholar] [DOI]
19 The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders
J. Bruins,F. Jörg,E.R. van den Heuvel,A.A. Bartels-Velthuis,E. Corpeleijn,F.A.J. Muskiet,G.H.M. Pijnenborg,R. Bruggeman
Schizophrenia Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
20 Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care
Shamima Saloojee,Jonathan K. Burns,Ayesha A. Motala
Early Intervention in Psychiatry. 2017;
[Pubmed]  [Google Scholar] [DOI]
21 Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium
Stijn Cleymans,Manuel Morrens,Chris Bervoets
Journal of Medical Ethics. 2017; 43(6): 359
[Pubmed]  [Google Scholar] [DOI]
22 Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control
Clara M. Franch Pato,Vicente Molina Rodríguez,Juan I. Franch Valverde
Revista de Psiquiatría y Salud Mental (English Edition). 2017; 10(1): 38
[Pubmed]  [Google Scholar] [DOI]
23 Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder
Razieh Nayerifard,majid akbari bureng,Alireza Zahiroddin,Massood Namjoo,Sepideh Rajezi
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]
24 Association Between 5-HTR2C -759C/T (rs3813929) and -697G/C (rs518147) Gene Polymorphisms and Risperidone-Induced Insulin Resistance Syndrome in an Indian Population
Saibal Das,Jayanta Kumar Dey,Niranjan Prabhu SS,Sachin David,Aniket Kumar,Deepa Braganza,Margaret Shanthi FX
The Journal of Clinical Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]
25 Estimating 10-year cardiovascular disease risk in Asian patients with schizophrenia
Gurpreet Rekhi,Toe Toe Khyne,Jimmy Lee
General Hospital Psychiatry. 2016; 43: 46
[Pubmed]  [Google Scholar] [DOI]
26 Prevalence of metabolic syndrome in female and male patients at risk of psychosis
Joachim Cordes,Andreas Bechdolf,Christina Engelke,Kai G. Kahl,Chakrapani Balijepalli,Christian Lösch,Joachim Klosterkötter,Michael Wagner,Wolfgang Maier,Andreas Heinz,Walter de Millas,Wolfgang Gaebel,Georg Winterer,Birgit Janssen,Christian Schmidt-Kraepelin,Frank Schneider,Martin Lambert,Georg Juckel,Thomas Wobrock,Michael Riedel,Susanne Moebus
Schizophrenia Research. 2016;
[Pubmed]  [Google Scholar] [DOI]
27 Factores determinantes del riesgo metabólico en el tratamiento con antipsicóticos atípicos
Clara M. Franch Pato,Vicente Molina Rodríguez,Juan I. Franch Valverde
Psiquiatría Biológica. 2016; 23(3): 128
[Pubmed]  [Google Scholar] [DOI]
28 Síndrome metabólico y antipsicóticos atípicos. Posibilidad de predicción y control
Clara M. Franch Pato,Vicente Molina Rodríguez,Juan I. Franch Valverde
Revista de Psiquiatría y Salud Mental. 2016;
[Pubmed]  [Google Scholar] [DOI]
29 Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic ß-cell function via glycogen synthase kinase-3ß
Agata Jurczyk,Anetta Nowosielska,Natalia Przewozniak,Ken-Edwin Aryee,Philip DiIorio,David Blodgett,Chaoxing Yang,Martha Campbell-Thompson,Mark Atkinson,Leonard Shultz,Ann Rittenhouse,David Harlan,Dale Greiner,Rita Bortell
The FASEB Journal. 2016; 30(2): 983
[Pubmed]  [Google Scholar] [DOI]
30 From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism
Rolando I. Castillo,Leonel E. Rojo,Marcela Henriquez-Henriquez,Hernán Silva,Alejandro Maturana,María J. Villar,Manuel Fuentes,Pablo A. Gaspar
Frontiers in Neuroscience. 2016; 10
[Pubmed]  [Google Scholar] [DOI]
31 Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics
Gail A. Edelsohn,Meghna Parthasarathy,Lauren Terhorst,Irina O. Karpov,James Schuster
Journal of Managed Care & Specialty Pharmacy. 2015; 21(9): 769
[Pubmed]  [Google Scholar] [DOI]
32 Weight Gain and its Correlates among Forensic Inpatients
N Zoe Hilton,Elke Ham,Carol Lang,Grant T Harris
The Canadian Journal of Psychiatry. 2015; 60(5): 232
[Pubmed]  [Google Scholar] [DOI]
33 Metabolic Syndrome Screening and Assertive Community Treatment
Enrico G. Castillo,Justin Rosati,Caroline Williams,Neil Pessin,David C. Lindy
Journal of the American Psychiatric Nurses Association. 2015; 21(4): 233
[Pubmed]  [Google Scholar] [DOI]
34 Can corneal confocal microscopy help in early detection of neuronal damage and cognitive dysfunction as a consequence of metabolic syndrome in schizophrenia?
Anoop Sankaranarayanan,Rayaz A. Malik
Early Intervention in Psychiatry. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
35 Persistence of racial disparities in prescription of first-generation antipsychotics in the USA
Thomas B. Cook,Gloria M. Reeves,James Teufel,Teodor T. Postolache
Pharmacoepidemiology and Drug Safety. 2015; 24(11): 1197
[Pubmed]  [Google Scholar] [DOI]
36 Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia
Marthoenis Marthoenis,Marion C. Aichberger,Ibrahim Puteh,Syahrial Syahrial,Meryam Schouler-Ocak
Asian Journal of Psychiatry. 2015; 15: 10
[Pubmed]  [Google Scholar] [DOI]
37 Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum
Ana C. Andreazza,Vilte E. Barakauskas,Salar Fazeli,Abigail Feresten,Li Shao,Vivien Wei,Che Hsuan Wu,Alasdair M. Barr,Clare L. Beasley
Neuroscience Letters. 2015; 591: 36
[Pubmed]  [Google Scholar] [DOI]
38 Prevalence and risk factors of metabolic syndrome among drug-naive psychotic patients
Nagy Fawzy,AmanyEl Shabrawy,Amira Youssef
Egyptian Journal of Psychiatry. 2015; 36(2): 101
[Pubmed]  [Google Scholar] [DOI]
39 Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders
Ching-I Hung,Chia-Yih Liu,Mei-Chun Hsiao,Nan-Wen Yu,Chun-Lin Chu
BMC Psychiatry. 2014; 14(1)
[Pubmed]  [Google Scholar] [DOI]
40 An Eight-Year Clinic Experience with Clozapine Use in a Parkinson’s Disease Clinic Setting
Nawaz Hack,Sarah M. Fayad,Erin H. Monari,Umer Akbar,Angela Hardwick,Ramon L. Rodriguez,Irene A. Malaty,Janet Romrell,Aparna A. Wagle. Shukla,Nikolaus McFarland,Herbert E. Ward,Michael S. Okun,Pedro Gonzalez-Alegre
PLoS ONE. 2014; 9(3): e91545
[Pubmed]  [Google Scholar] [DOI]

 

Read this article